References
- Stein H, Lennert K, Feller A C, et al. Immunohistochemical analysis of human lymphoma: correlation of histologic and immunological categories. Adv Cancer Res 1984; 42: 67–147
- Zuckerberg L R, Medeiros L J, Ferry J A, et al. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Pathol 1993; 100: 373–385
- Pallesen G. The distribution of CD23 in normal human tissues and in malignant lymphomas. Leukocyte Typing III, A J McMichael. Oxford University Press, New York 1987; 383
- Dorfman D M, Pinkus G S. Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23. Mod Pathol 1994; 7: 326–331
- Kilo M N, Dorfman D M. The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma. Am J Clin Pathol 1996; 105: 441–45
- Kumar S, Green G A, Teruya-Feldstein J, et al. Use of CD23 (BU38) on paraffin sections in the diagnosis of small lymphocyte lymphoma and mantle cell lymphoma. Mod Pathol 1996; 9: 925–929
- Dunphy C H, Wheaton S E, Perkins S L. CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma. Mod Pathol 1997; 10(8)818–822
- Dunphy C H, Dunphy F R. Prolymphocytoid variant of mantle cell lymphoma: a previously undescribed form. J Surg Pathol 1998; 3: 47–50
- Narang S, Wolf B C, Neiman R S. Malignant lymphoma presenting with prominent splenomegaly: a clinico-pathologic study with special reference to intermediate cell lymphoma. Cancer 1985; 55: 1948–1957
- Duggan M J, Weisenburger D D, Ye Y L, et al. Mantle zone lymphoma: a clinicopathologic study of 22 cases. Cancer 1990; 66: 522–529
- Zucca E, Roggero E, Pinotii G. Patterns of survival in mantle cell lymphoma. Ann Oncol 1995; 6: 257–262
- Zucca E, Fontana S, Roggero E, et al. Treatment and prognosis of centrocytic (mantle cell) lymphoma: a retrospective analysis of twenty-six patients treated in one institution. Leuk Lymphoma 1994; 13: 105–110
- Shivdasani R A, Hess J L, Skarin A T, et al. Intermediate lymphocytic lymphoma: clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma. J Clin Oncol 1993; 11: 802–811
- Lardelli P, Bookman M A, Sundeen J, et al. Lymphocytic lymphoma of intermediate differentiation: morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol 1990; 14(8)752–763
- Dunphy C H, Hancock J C, Rodriguez J J, et al. Blastic mantle cell leukemia: a previously undescribed form. Journal of Clinical Laboratory Analysis 1999; 13: 112–115
- Singleton T P, Anderson M M, Ross C W, et al. Leukemic phase of mantle cell lymphoma, blastoid variant. Am J Clin Pathol 1999; 111: 495–500
- Kobayashi H, Kitanok Saitoh, et al. Overexpression of the PRAD1 oncogene in a patient with prolymphocytic leukemia with t(11;14) (q13;q32). Cancer Genet Cytogenet 1995; 84: 69–72